Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study

Abstract Background Our aim was to investigate dynamic changes in hepatitis B virus (HBV) surface antibody (HBsAb) titer and the associated risk of HBV reactivation and clinical course in patients with HBV surface antigen negative/core antibody positive (HBsAg−/HBcAb+) serostatus during antirheumati...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2018-11-01
Saila:Arthritis Research & Therapy
Gaiak:
DMARDs (biologic)
Hepatitis B virus surface/core antibody (HBsAb/HBcAb)
Rheumatic diseases
HBV reactivation
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s13075-018-1748-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Lanean...

Antzeko izenburuak